Cancer · 1967 · 174 citations · 40 references
MedicineHematologyOncologyChemotherapyHematology PhysiologyHemostasisCoagulation AbnormalitiesCoagulation DisordersCoagulation PhysiologyHemostatic DisordersPlatelet PhysiologyThrombosisBleedingCoagulationCoagulation Cascade DysregulationCoagulation DysregulationCoagulation Time MeasurementLaboratory AbnormalitiesThrombosis MechanismsVitamin K-dependent Coagulation Disorders
A comprehensive study of the hemostatic and coagulation mechanisms in 50 patients with disseminated malignancy was carried out. Significant laboratory abnormalities were found in the majority of patients. The most common pattern was the “hypercoagulable state.” This included short bleeding time, decreased silicone coagulation time and partial thromboplastin time, increased tolerance to heparin, marked elevation of plasma levels of factors I, II, V, VIII, IX and XI and acceleration of thromboplastin generation. There was elevation of platelet counts, except in patients receiving chemotherapeutic drugs. Seven patients had prolonged prothrombin time due to depression of vitamin-K-dependent clotting factors. Fibrinolysis was detected in six patients by immunologic and other techniques. The data suggest that patients with cancer have an alteration in the hemostatic level of control with increased levels of both clotting factors and their inhibitors, resulting in a more easily disturbed balance between opposing hemostatic forces. Clinical thrombosis or bleeding may follow.
40
Experiments on a new Clotting Factor (Factor VII)
F Koller, A Loeliger, F Duckert · Acta Haematologica · 2009 · 297 citations
Medicine, Hematology, Physiology +13
Thrombocytosis Associated With Malignant Disease
Jack Levin · Archives of Internal Medicine · 1964 · 293 citations
Medicine, Hematology, Oncology +11
STUDIES ON ENHANCED FIBRINOLYTIC ACTIVITY IN MAN*
Sol Sherry, Robert I. Lindemeyer, Anthony P. Fletcher et al. · Journal of Clinical Investigation · 1959 · 281 citations · Full text